
Management of M/XDR-TB Treatment During Pregnancy
Managing M/XDR-TB during pregnancy involves gestational age-based decisions. For pregnancies ≤ 20 weeks, medical termination may be advised due to severe risks, followed by shorter Bedaquiline-containing MDR/RR-TB regimens.
